Click Here for 5% Off Your First Aladdin Purchase!

SNX0723 , CAS No.S613648, Inhibitor of heat shock protein 90 alpha family class A member 1

  • Moligand™
Item Number
S613648
Grouped product items
SKUSizeAvailabilityPrice Qty
S613648-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$304.90
S613648-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,064.90

Basic Description

Specifications & PurityMoligand™
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of heat shock protein 90 alpha family class A member 1

Associated Targets

HSP90B1 Tchem Endoplasmin 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TRAP1 Tchem Heat shock protein 75 kDa, mitochondrial 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HSP90AA1 Tchem Heat shock protein HSP 90-alpha 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HSP90AB1 Tchem Heat shock protein HSP 90-beta 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-fluoro-6-[[(3S)-oxolan-3-yl]amino]-4-(3,6,6-trimethyl-4-oxo-5,7-dihydroindol-1-yl)benzamide
INCHI InChI=1S/C22H26FN3O3/c1-12-10-26(17-8-22(2,3)9-18(27)19(12)17)14-6-15(23)20(21(24)28)16(7-14)25-13-4-5-29-11-13/h6-7,10,13,25H,4-5,8-9,11H2,1-3H3,(H2,24,28)/t13-/m0/s1
InChi Key GAGDTKJJVCLACJ-ZDUSSCGKSA-N
Canonical SMILES NC(=O)c1c(N[C@@H]2COCC2)cc(cc1F)n1cc(c2c1CC(C)(C)CC2=O)C
Isomeric SMILES CC1=CN(C2=C1C(=O)CC(C2)(C)C)C3=CC(=C(C(=C3)F)C(=O)N)N[C@H]4CCOC4
PubChem CID 67495834

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Putcha P, Danzer KM, Kranich LR, Scott A, Silinski M, Mabbett S, Hicks CD, Veal JM, Steed PM, Hyman BT et al..  (2010)  Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity..  J Pharmacol Exp Ther,  332  (3): (849-57).  [PMID:19934398]
2. A-González N, Castrillo A.  (2011)  Liver X receptors as regulators of macrophage inflammatory and metabolic pathways..  Biochim Biophys Acta,  1812  (8): (982-94).  [PMID:21193033]
3. Ernst JT, Liu M, Zuccola H, Neubert T, Beaumont K, Turnbull A, Kallel A, Vought B, Stamos D.  (2014)  Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases..  Bioorg Med Chem Lett,  24  (1): (204-8).  [PMID:24332488]
4. Huyan T, Li Q, Dong DD, Yang H, Zhang J, Huang QS, Yin DC, Shang P.  (2016)  Heat shock protein 90 inhibitors induce functional inhibition of human natural killer cells in a dose-dependent manner..  Immunopharmacol Immunotoxicol,  38  (2): (77-86).  [PMID:26642940]

Solution Calculators